The association between continuous renal replacement therapy as treatment for sepsis-associated acute kidney injury and trend of lactate trajectory as risk factor of 28-day mortality in intensive care units
Tóm tắt
Sepsis has high incidence and fatality rates in intensive care units, often leading to renal failure. The effectiveness of continuous renal replacement therapy (CRRT) in sepsis-associated acute kidney injury (S-AKI) patients is currently uncertain. Joint model was used to determine the association between CRRT and the lactate trajectory trend and how it correlated to 28-day mortality for S-AKI patient in ICU. A retrospective study was applied to patients with sepsis and AKI, which were extracted from the MIMIC-III public database, with the endpoint being 28-day mortality. Every lactate level measurement within 28 days was observed and calculated using logarithms. Joint model combined the longitudinal analysis of the natural logarithm of the lactate level [log(lactate)] in longitudinal submodel and Cox regression by trajectory function, demonstrating the effects of CRRT on 28-day survival and log(lactate) changes, and its final relationship with the event status. Among the 717 S-AKI patients, 157 received CRRT. CRRT was not associated with 28-day mortality. After adjustments, the relationship between CRRT use and log(lactate) elevation was statistically significant. The parameter estimation of CRRT and log(lactate) indicated that using CRRT will increase log(lactate) by 0.041 in S-AKI patients. The joint model also instigated a fixed association between changes in the lactate level and the event result, revealing an exp value of (0.755) = 2.12, indicating that an increase of one unit in log(lactate) will increase the risk of 28-day mortality 2.12-times. There was no significant association between CRRT use and 28-day survival in S-AKI patients, and JM showed that CRRT use might be associated with elevation of longitudinal lactate levels. Therefore, additional attention should be paid to other treatments to control lactate levels when providing renal support for patients with S-AKI.
Tài liệu tham khảo
Bracht H, Hafner S, Weiß M. Sepsis Update: Definition and Epidemiology. Anasthesiol Intensivmed Notfallmed Schmerzther. 2019;54(1):10–20. https://doi.org/10.1055/a-0625-5492.
Cecconi, Maurizio, Evans, et al. Sepsis and septic shock. Lancet. 2018.
Nolt B, Tu F, Wang X, et al. Lactate and Immunosuppression in Sepsis. Shock. 2018;49(2):120–5. https://doi.org/10.1097/SHK.0000000000000958.
Chertoff J, Chisum M, Garcia B, Lascano J. Lactate kinetics in sepsis and septic shock: a review of the literature and rationale for further research. J intensive care. 2015;3:39. https://doi.org/10.1186/s40560-015-0105-4.
Poston JT, Koyner JL. Sepsis associated acute kidney injury. BMJ. 2019;364: k4891. https://doi.org/10.1136/bmj.k4891.
Bagshaw SM, George C, Bellomo R, Committee ADM. Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care. 2008;12(2):R47–R47. https://doi.org/10.1186/cc6863.
Pozzato M, Livigni S, Roccatello D. [Extracorporeal therapy in sepsis]. G Ital di Nefrol organo Uff della Soc Ital di Nefrol. 2019;36(2).
Romagnoli S, Ricci Z, Ronco C. CRRT for sepsis-induced acute kidney injury. Curr Opin Crit Care. 2018;24(6). https://journals.lww.com/co-criticalcare/Fulltext/2018/12000/CRRT_for_sepsis_induced_acute_kidney_injury.10.aspx.
da Hora Passos R, Ramos JGR, Gobatto A, et al. Lactate clearance is associated with mortality in septic patients with acute kidney injury requiring continuous renal replacement therapy: a cohort study. Medicine. 2016;95(40):e5112. https://doi.org/10.1097/MD.0000000000005112.
Cheungpasitporn W, Zand L, Dillon JJ, Qian Q, Leung N. Lactate clearance and metabolic aspects of continuous high-volume hemofiltration. Clin Kidney J. 2015;8(4):374–7. https://doi.org/10.1093/ckj/sfv045.
Liu Y, Ouyang B, Chen J, et al. Effects of different doses in continuous veno-venous hemofiltration on plasma lactate in critically ill patients. Chin Med J (Engl). 2014;127(10):1827–32.
Ibrahim JG, Chu H, Chen LM. Basic concepts and methods for joint models of longitudinal and survival data. J Clin Oncol. 2010;28(16):2796–801. https://doi.org/10.1200/JCO.2009.25.0654.
Commenges D, Jacqmin-Gadda H. - Joint Models for Longitudinal and Time-to-Event Data.; 2020. doi:https://doi.org/10.1201/b19109-17
Johnson AEW, Pollard TJ, Shen L, et al. MIMIC-III, a freely accessible critical care database. entific Data.
Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–10. https://doi.org/10.1001/jama.2016.0287.
Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care. 2013;17(1):204. https://doi.org/10.1186/cc11454.
Regueira T, Andresen M, Mercado M, Downey P. Physiopathology of acute renal failure during sepsis. Med intensiva. 2011;35(7):424–32. https://doi.org/10.1016/j.medin.2011.03.011.
Prowle JR, Schneider A, Bellomo R. Clinical review: Optimal dose of continuous renal replacement therapy in acute kidney injury. Crit Care. 2011;15(2):207. https://doi.org/10.1186/cc9415.
Michael, Joannidis. THE CLINICAL APPLICATION OF CRRT—CURRENT STATUS: Continuous Renal Replacement Therapy in Sepsis and Multisystem Organ Failure. Semin Dial. 2009.
Zhang J, Tian J, Sun H, et al. How Does Continuous Renal Replacement Therapy Affect Septic Acute Kidney Injury? Blood Purif. 2018;46(4):326–31. https://doi.org/10.1159/000492026.
Van Wert R, Friedrich JO, Scales DC, Wald R, Adhikari NKJ, Group for the U of TAKIR. High-dose renal replacement therapy for acute kidney injury: Systematic review and meta-analysis. Crit Care Med. 2010;38(5). https://journals.lww.com/ccmjournal/Fulltext/2010/05000/High_dose_renal_replacement_therapy_for_acute.18.aspx.
Li P, Qu L, Qi D, et al. High-dose versus low-dose haemofiltration for the treatment of critically ill patients with acute kidney injury: an updated systematic review and meta-analysis. BMJ Open. 2017;7(10): e014171. https://doi.org/10.1136/bmjopen-2016-014171.
Hsu Y-C, Hsu C-W. Septic acute kidney injury patients in emergency department: The risk factors and its correlation to serum lactate. Am J Emerg Med. 2019;37(2):204–8. https://doi.org/10.1016/j.ajem.2018.05.012.
Serum lactates and acute kidney injury in patients with sepsis: A cohort analysis. Cogent Med. 2017;4(1).
Aliustaoglu Bayar AE, Aksay E, Oray NC. Lactate measurements accurately predicts 1-week mortality in emergency department patients with acute kidney injury. Turkish J Emerg Med. 2019;19(4):136–40. https://doi.org/10.1016/j.tjem.2019.08.002.
Page B, Vieillard-Baron A, Chergui K, et al. Early veno-venous haemodiafiltration for sepsis-related multiple organ failure. Crit Care. 2005;9(6):R755–63. https://doi.org/10.1186/cc3886.
Morgera S, Heering P, Szentandrasi T, et al. Comparison of a lactate-versus acetate-based hemofiltration replacement fluid in patients with acute renal failure. Ren Fail. 1997;19(1):155–64. https://doi.org/10.3109/08860229709026270.
Davenport A, Will EJ, Davison AM. The effect of lactate-buffered solutions on the acid-base status of patients with renal failure. Nephrol Dial Transplant. 1989;4(9):800–4.
Jacobi J. Pathophysiology of sepsis. Am J Heal Pharm. 2002;59(Suppl 1):S3-8. https://doi.org/10.1093/ajhp/59.suppl_1.S3.